Ken Griffin
JUNS

Ken Griffin’s Jupiter Neurosciences JUNS Stock Holding History

Ken Griffin’s Portfolio JUNS Stock Details JUNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$38.2K Buy
+1,355
New +$62.5K ﹤0.01% 12507

Other funds holding JUNS

VC
Vestor Capital Chicago, Illinois $1.59M AUM 51.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
YAG
Yorkville Advisors Global Mountainside, New Jersey $86.2M AUM 41.28% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
MB
MidFirst Bank Oklahoma City, Oklahoma $1.41B AUM

Ken Griffin's JUNS Position: Q1 2026 in Review

Ken Griffin opened a new position in Jupiter Neurosciences (JUNS) in Q1 2026: 1,355 shares worth $38.2K. The stake represents ﹤0.01% of the portfolio and ranks #12507 among its holdings.

10 funds tracked by Wall St. Rank hold JUNS as of Q1 2026.

  • Ken Griffin held 1,355 shares of Jupiter Neurosciences worth $38.2K as of Q1 2026.
  • Jupiter Neurosciences was a new Ken Griffin position in Q1 2026.
  • Jupiter Neurosciences made up ﹤0.01% of Ken Griffin's portfolio in Q1 2026, its #12507 holding.
  • 10 funds tracked by Wall St. Rank held Jupiter Neurosciences as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.